Arcadia Biosciences Inc (RKDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Sales | 1,823 | 1,430 | 815 | 2,798 | 1,502 |
| Cost of Goods | 61 | 106 | 56 | 70 | 1,795 |
| Gross Profit | 1,762 | 1,324 | 759 | 2,740 | -293 |
| Operating Expenses | 6,058 | 4,977 | 4,526 | 4,450 | 6,445 |
| Operating Income | -4,235 | -3,547 | -3,711 | -1,652 | -5,943 |
| Interest Expense | 766 | 775 | 467 | 360 | 265 |
| Other Income | 285 | 735 | -1,396 | 42 | -813 |
| Pre-tax Income | -4,716 | -3,587 | -5,574 | -1,970 | -7,021 |
| Income Tax | -97 | 90 | 229 | 40 | 43 |
| Net Income Continuous | -4,619 | -3,677 | -5,803 | -1,988 | -7,064 |
| Net Income | $-4,619 | $-3,677 | $-5,803 | $-1,988 | $-7,064 |
| EPS Basic Total Ops | -88.00 | -152.00 | -2,968.00 | -1,408.00 | -3,352.00 |
| EPS Basic Continuous Ops | -84.66 | -123.73 | -2,237.30 | -764.62 | -2,740.64 |
| EPS Diluted Total Ops | -88.00 | -152.00 | -2,968.00 | -1,408.00 | -3,352.00 |
| EPS Diluted Continuous Ops | -84.66 | -123.73 | -2,237.30 | -764.62 | -2,740.64 |
| EBITDA(a) | $-4,166 | $-3,478 | $-3,639 | $-1,574 | $-5,854 |